Latest filing published 02 Apr 2026 for Bristol Myers Squibb Co.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Karin Shanahan in Bristol Myers Squibb Co. Over a trading history stretching from 10 March 2023 to 1 April 2026, the count stands at 31 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 2 April 2026, reports an option exercise in Bristol Myers Squibb Co. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations